Notice convening the Ordinary Shareholders Meeting and documents relating to the Ordinary Shareholders Meeting

Current report no. 20/2023

Date of drafting: 30 May 2023.

Subject: Notice convening the Ordinary Shareholders Meeting and documents relating to the Ordinary Shareholders Meeting

Legal basis: Article 56(1)(2) of the Act on Offering – current and periodic information

The Board of Directors of Captor Therapeutics S.A., with its registered office in Wrocław (the “Company”), acting on the basis of Article 399 § 1 in connection with Articles 402¹ and 402² of the Commercial Companies Code, announces that the Ordinary Shareholders Meeting of the Company has been convened for 26 June 2023, at 2:00 p.m. and will be held in Wrocław at 9 Duńska (54-427 Wrocław), in the “DELTA” building.

The Company's Management Board provides the following in the appendix to this report:

1. the full text of the announcement with the agenda of the Ordinary Shareholders Meeting (Appendix  1),
2. draft resolutions to be discussed at the Ordinary Shareholders Meeting of the Company (Appendix  2);
3. content of the resolution of the Supervisory Board giving a positive opinion on the draft resolutions to be discussed at the Ordinary Shareholders Meeting of the Company (Appendix 3);
4. the remuneration report prepared by the Company's Supervisory Board for 2022 (Appendix 4);
5. independent auditor's report on the performance of an assurance service providing reasonable assurance on the assessment of the Captor Therapeutics S.A. remuneration report for 2022 (Appendix 5);
6. the report of the Company's Supervisory Board for 2022 (Appendix 6).